Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan

被引:71
作者
Yamaguchi, T
Yokota, Y
Terajima, J
Hayashi, T
Aepfelbacher, M
Ohara, M
Komatsuzawa, H
Watanabe, H
Sugai, M
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Bacteriol, Minami Ku, Hiroshima 7348553, Japan
[2] Fujisawa Pharmaceut Co Ltd, Dev Div, Pharma Clin Res, Osaka 532, Japan
[3] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan
[4] Miyazaki Med Coll, Dept Microbiol, Miyazaki 88916, Japan
[5] Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany
关键词
D O I
10.1086/340212
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A molecular epidemiological analysis was performed to reveal the clonal association of Staphylococcus aureus strains isolated from patients with bullous impetigo. Pulsed-field gel electrophoresis with cluster analysis, genetic and phenotypic characterizations, and antimicrobial susceptibility profiling of 88 S. aureus strains isolated from outpatients at 4 hospitals in the Kansai district in Japan were undertaken. Three distinct clonal groups were identified: 2 of them carried the exfoliative toxin (ET) A gene (eta), and the other carried the ETB gene (etb). The former groups represent 2 eta-positive clonal groups that have not been described previously. All the strains in the more dominant eta-positive clonal group and some of the strains in the etb-positive clonal group were methicillin-resistant S. aureus (MRSA) showing borderline-to-moderate resistance to beta-lactams. These MRSA strains appear to be emerging clonal groups that have not been considered in previous epidemiological studies of ET-producing S. aureus in Japan and thus pose a significant threat for future treatment of patients with bullous impetigo and/or staphylococcal scalded-skin syndrome.
引用
收藏
页码:1511 / 1516
页数:6
相关论文
共 16 条
[1]   Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 [J].
Amagai, M ;
Matsuyoshi, N ;
Wang, ZH ;
Andl, C ;
Stanley, JR .
NATURE MEDICINE, 2000, 6 (11) :1275-1277
[2]   QUALITATIVE AND QUANTITATIVE METHODS FOR DETECTING STAPHYLOCOCCAL EPIDERMOLYTIC TOXIN [J].
ARBUTHNOTT, JP ;
BILLCLIFFE, B .
JOURNAL OF MEDICAL MICROBIOLOGY, 1976, 9 (02) :191-+
[3]  
DEAZAVEDO J, 1981, J MED MICROBIOL, V14, P341, DOI 10.1099/00222615-14-3-341
[4]   STAPHYLOCOCCAL SCALDED SKIN SYNDROME [J].
ELIAS, PM ;
FRITSCH, P ;
EPSTEIN, EH .
ARCHIVES OF DERMATOLOGY, 1977, 113 (02) :207-219
[5]   Staphylococcal scalded-skin syndrome [J].
Farrell, AM .
LANCET, 1999, 354 (9182) :880-881
[6]   Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis [J].
Kanzaki, H ;
Ueda, M ;
Morishita, Y ;
Akiyama, H ;
Arata, J ;
Kanzaki, S .
DERMATOLOGY, 1997, 195 (01) :6-9
[7]   PURIFICATION OF EXFOLIATIN PRODUCED BY STAPHYLOCOCCUS-AUREUS OF BACTERIOPHAGE GROUP-2 AND ITS PHYSICOCHEMICAL PROPERTIES [J].
KONDO, I ;
SAKURAI, S ;
SARAI, Y .
INFECTION AND IMMUNITY, 1973, 8 (02) :156-164
[8]   Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome [J].
Ladhani, S ;
Joannou, CL ;
Lochrie, DP ;
Evans, RW ;
Poston, SM .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) :224-+
[9]   STAPHYLOCOCCAL SCALDED SKIN SYNDROME - EXPANDED CLINICAL SYNDROME [J].
MELISH, ME ;
GLASGOW, LA .
JOURNAL OF PEDIATRICS, 1971, 78 (06) :958-+
[10]   MICROBIOLOGIC CHARACTERISTICS OF EXFOLIATIVE TOXIN-PRODUCING STAPHYLOCOCCUS-AUREUS [J].
MURONO, K ;
FUJITA, K ;
YOSHIOKA, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (05) :313-315